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In the developing nervous system, the balance between proliferation and differentiation is critical to generate the appropriate numbers and
types of neurons and glia. Notch signaling maintains the progenitor pool throughout this process. While many components of the Notch pathway
have been identified, the downstream molecular events leading to neural differentiation are not well understood. We have taken advantage of a
small molecule inhibitor, DAPT, to block Notch activity in retinal progenitor cells, and analyzed the resulting molecular and cellular changes over
time. DAPT treatment causes a massive, coordinated differentiation of progenitors that produces cell types appropriate for their developmental
stage. Transient exposure of retina to DAPT for specific time periods allowed us to define the period of Notch inactivation that is required for a
permanent commitment to differentiate. Inactivation of Notch signaling revealed a cascade of proneural bHLH transcription factor gene expression
that correlates with stages in progenitor cell differentiation. Microarray/QPCR analysis confirms the changes in Notch signaling components, and
reveals new molecular targets for investigating neuronal differentiation. Thus, transient inactivation of Notch signaling synchronizes progenitor
cell differentiation, and allows for a systematic analysis of key steps in this process.
© 2007 Elsevier Inc. All rights reserved.Keywords: Notch activity; Hes1; Hes5; Proneural bHLH transcription factor; Progenitor cell; Neural differentiation; Insulinoma-associated 1Introduction
The Notch signaling pathway is critical for many aspects of
neural development. Notch-Delta signaling is thought tomediate
most, if not all, lateral inhibitory interactions necessary for
patterning neural cells (Lewis, 1996; Lowell, 2000). Notch
activity in the retina is necessary in progenitor cells to maintain
their undifferentiated state throughout the neurogenic period
(Dorsky et al., 1995, 1997; Austin et al., 1995; Tomita et al.,
1996; Henrique et al., 1997; Furukawa et al., 2000; Hojo et al.,
2000; Satow et al., 2001; Silva et al., 2003; Takatsuka et al.,
2004; Nelson et al., 2006; Jadhav et al., 2006; Yaron et al., 2006).
Notch is also important in promoting the glial fate in multi-
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doi:10.1016/j.ydbio.2007.01.001of neural stem and progenitor cells, and newly generated
neurons (Gaiano and Fishell, 2002; Mason et al., 2006).
Despite the wealth of data on the functions of Notch
signaling in development, there are some key aspects of this
pathway that are not well understood. For example, while
only a brief period of Notch signaling activation is required
to cause multipotent neural crest stem cells to develop into
glia (Morrison et al., 2000), no study has defined the period
of time during which the Notch signal has to be inactive in
order to cause neural differentiation. In addition, while many
of the components of the Notch pathway have been
identified in genetic screens, we know little of the cascade
or kinetics of downstream molecular events that lead to
neural differentiation following inactivation of this signaling
pathway.
Analysis of the extensive number of mutant Notch alleles in
Drosophila reveals that Notch signaling can be separated into
two categories, canonical and non-canonical (reviewed by
Martinez Arias et al., 2002). Canonical Notch signaling is active
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(Jagged)/Lag) ligand-regulated binding of the extracellular
domain of Notch (discussed by Chitnis, 2006). Binding of DSL
ligands to Notch allows access of a presenilin/γ-secretase
complex to cleave and release the Notch internal cytoplasmic
domain (NICD). Then NICD translocates to the nucleus and
forms a transcriptional activation complex with CSL/RBP-jK
and Mastermind (reviewed by Mumm and Kopan, 2000; Selkoe
and Kopan, 2003). This activation complex positively regulates
transcription of Notch target genes, such as the Hes genes, that
act as effectors of Notch signaling.
The presenilin/γ-secretase complex necessary for canonical
Notch signaling is composed of at least four proteins
(presenilin, nicastrin, pen-2, and Aph-1) that regulate intra-
membrane proteolysis (RIPping) of type I membrane proteins
(Brown et al., 2000; Chyung et al., 2005). All mammalian
Notch family members (Notch1–4) require presenilin/γ-secre-
tase-mediated release of their intracellular domains for their
canonical activities (Saxena et al., 2001). Presenilin mutations
are frequently used to analyze loss-of-function of the Notch
signaling pathway (for example see Alexson et al., 2006;
Mizuguchi et al., 2006). Additionally, γ-secretase inhibitors that
have been developed largely as a means to treat Alzheimer's
disease (reviewed by Tsai et al., 2002) have also been used to
inhibit the Notch pathway. One γ-secretase inhibitor, DAPT,
has been shown to phenocopy various Notch mutations in both
zebrafish and Drosophila (Geling et al., 2002; Micchelli et al.,
2003) and downregulates Hes1 and Hes5 gene expression and
reporter activity (Ong et al., 2006; Nelson et al., 2006).
In this study, we have taken advantage of DAPT treatment to
inactivate Notch signaling in retinal progenitors. We show that
DAPT treatment causes a massive, synchronized differentiation
of neural progenitors, leading to premature differentiation of
stage-appropriate cell types. Temporal analysis of gene
expression defines the cascade and kinetics of molecular
changes that lead to neural differentiation. We define the
amount of time that Notch must be inactivated that will lead to a
permanent commitment of the progenitors to differentiate. We
also show that a cascade of transiently and sequentially
upregulated proneural bHLH transcription factor genes corre-
lates with stages in neural differentiation. Microarray analysis
confirms the early molecular changes in expression of Notch
pathway components and identifies new immediate targets in
the differentiation cascade. Thus, precise temporal control over
neural progenitor cell differentiation allows systematic analysis
of this process.Methods
Animals and tissues
Fertilized white leghorn chicken eggs (Hyline) were incubated to embryonic
day 4.5 (E4.5, stage 25; Hamburger and Hamilton, 1951) and pairs of eyes were
collected in HBSS+ (Gibco/BRL). Extra-ocular tissues and pigmented
epithelium were removed. Pairs of retinas were transferred to a 24-well plate
(Falcon, 351147) and cultured (as described in Nelson et al., 2006) for 2–4 days
at 37 °C with nutation. Pairs of retinas were collected from embryonic day E12.5
and postnatal day P1 mice (C57Bl6 or Swiss Webster), and were cultured asabove with gentle nutation. Tissue harvest was carried out according to approved
protocols at the University of Washington. Mice were housed in the Department
of Comparative Medicine. Insm1:LacZ mice are described in (Breslin et al.,
2003).
The γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenyl-
glycine t-butyl ester (DAPT; Sigma) was used to inhibit the γ-secretase-
dependent S3 cleavage of Notch, which releases the Notch internal cytoplasmic
domain NICD (Geling et al., 2002). We previously demonstrated that DAPT
induced neuronal differentiation in a concentration-dependent manner, with
10 μM giving optimal results without precipitating in culture (Nelson et al.,
2006). DAPT (10 μM) was added to one retina, while an equal volume of
DMSO was added to the sister retina as vehicle control. For some experiments,
chick retinas were bisected and one half treated with DAPT, while the other half
served as DMSO control. For transient inhibition of Notch signaling, E4.5 chick
retinal explants were prepared as described above and incubated in the presence
of DAPT (10 μM) or DMSO for 1 h, 3 h, 6 h, 12 h, 24 h, and 48 h: explants were
then washed with media three times at the respective timepoint and cultured for a
total of 48 h.
Quantification of changes in gene expression
Quantitative reverse transcriptase PCR (QPCR) was used to measure
changes in gene expression levels due to DAPT treatment at 3 h, 6 h, 12 h, 24 h,
and 48 h of culture (as described in Nelson et al., 2006). Briefly, the lens and any
remaining pigmented epithelium were removed, and total RNA was extracted
with Trizol (Invitrogen) followed by digestion with RQ1 RNase-free DNase
(Promega) and purified with RNeasy columns (Qiagen). This RNA served as
template for oligo-dT-primed cDNA synthesis with SuperScriptII Reverse
Transcriptase (RT; Invitrogen): an RT minus control reaction was also included
for each sample. QPCR was performed with SYBR Green QPCR Master Mix
(Applied Biosystems) and an Opitocon DNA Engine Real-Time QPCR machine
(MJ Research). Sample concentrations were normalized to GAPDH according to
the respective ratios of GAPDH levels per retinal pair, with three pairs of retinas
analyzed per time point. Student's t-test was used to determine significance at
each time point, ANOVA was used to determine significance between time
points, and changes of P<0.05 were considered significant.
Microarray analysis was used to compare global gene expression changes
between E14.5 mouse retinas treated with DAPT for 8 h and DMSO controls.
Total RNA was pooled from each condition (n=12 retinas per condition), and
used to generate probes for hybridization to Affymetrix microarrays (Affymetrix
Mouse Genome 430 2.0 Array; Center for Expression Arrays, University of
Washington). QPCR was used to confirm changes of selected genes from the
microarray. Total RNA isolated from three separate litters (E14.5–E15.5 mice,
9–12 retinas treated with DAPT or DMSO for 8 h per condition, n=3), as
prepared for the microarray study, was used for QPCR as described. The
majority of mouse primers were obtained from PrimerBank (Wang and Seed,
2003; all primer sets are available upon request).
Transfections
E5.5 chick retinas were collected, dissociated by trypsin, triturated into
single cells, and transfected with GFP control plasmid (Nelson et al., 2006) or
NICD-IRES-GFP plasmid (Daudet and Lewis, 2005). Electroporation condi-
tions were 25 μg DNA per 400 μl cells, 3 pulses, 537V, 50 ms pulse length,
100 ms pulse interval (2 mm cuvettes, BTX T 820). Transfected cells were
plated onto poly-D-lysine/laminin-coated coverslips and grown overnight in
culture medium. DAPT (10 μM) was added to one set of GFP- and NICD-
transfected wells, while DMSO was added to the control set of wells. The cells
were cultured for an additional 48 h. After the culture period, cells were fixed
with 4% paraformaldehyde for 30 min, immunolabeled with a rabbit anti-GFP
antibody (1:2000, Dr. L. Berthiaume, University of Alberta), and goat-anti-
rabbit ALEXA 488 (1:500, Molecular Probes).
Immunolabeling
Explants were fixed in 4% paraformaldehyde for 30 min at room
temperature and immunolabeled as cryosections or wholemounts. Explants
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higher sucrose concentrations before embedding in O.C.T. (Tissue-Tek).
Sections and wholemounts were rinsed in PBS and blocked in 10% goat
serum–1× PBS–0.1% Triton X-100 (PBT). Primary antibodies include rabbit
and rat anti-Phospho Histone 3 (PH3, 1:750 dilution, Upstate and Novus,
respectively), rabbit anti-Visinin (1:3000, A. Polans, University of Wisconsin),
rat anti-BrdU (1:200 dilution; Accurate Chemical), rabbit anti-Trβ2 (1:500, D.
Forrest, NIH), mouse anti-Pax6 (1:20 dilution) and mouse anti Isl1 (1:5 dilution;
DHSB, Developmental Hybridoma Studies Bank), rabbit anti-Prox1 (1:1000
dilution, Chemicon), mouse anti-TUJ1 (1:750 dilution, Covance), mouse anti-
Cyclin D3 (1:200 dilution, Lab Vision Corp.), rabbit anti-CRALBP (1:200
dilution, J. Saari, University of Washington), rabbit anti-Recoverin (1:1000
dilution, Chemicon), rabbit anti-Rho4D2 (rhodopsin, 1:1000 diltution, DHSB).
For BrdU immunolabeling, sections were incubated with rat anti-BrdU antibody
and DNase 1 (1:100, Sigma) overnight. Secondary antibodies were species-
specific AlexaFluor 488 or 568 nm depending on the desired wavelength (1:500,
Molecular Probes). Sections were mounted in Fluoromount-G (Southern
Biotechnology Associates). Explants were mounted in 50% glycerol/PBS.
Sections were imaged with an epifluorescent Zeiss Axioscope equipped with
appropriate filter sets and Normarski/DIC optics and a Spot Camera, and/or a
Zeiss Pascal laser scanning confocal microscope (LSCM, Carl M. Zeiss, Inc.).
Explants were imaged with a fluorescent stereo dissecting scope (Nikon, eGFP/
Texas Red filter set, equipped with a Spot Camera), and/or LSCM.
For activated Notch1 (actN1) immunolabeling, a modified protocol based on
that described in Tokunaga et al. (2004) was used. Briefly, 6 μm paraffin
sections from E14.5 mouse embryo that received a 1 h pulse of BrdU in utero
prior to sacrifice were de-paraffinized and rehydrated. Antigen retrieval was
accomplished by autoclave treatment (5 min, 105 °C) in TE buffer (10 mM
TrisCl, 1 mM EDTA, pH 9.0). Sections were washed with PBS, blocked in 10%
goat serum in PBT for 1 h, incubated with rabbit-actN1antibody (1:500, cleaved
Notch 1 Val1744, Cell Signaling Tech.) overnight, washed 4× with PBS,
incubated with goat-anti rabbit:alkaline phosphatase (1:500, Sigma) for 1 h,
washed 4× with PBT, equilibrated with NTMT, pH 9.0, and incubated in NBT/
BCIP substrate (Sigma). Sections were washed in PBS and subjected to
sequential immunolabeling and fluorescent detection with primary and
secondary antibodies as described, followed by Dapi counterstaining and
mounting.
Results
Kinetics of Notch signaling inactivation
To determine the time-course of molecular changes due to
loss of Notch activity, we treated embryonic day 4.5 (E4.5)
chick retinal explants with DAPT. Pairs of retinal explants
were cultured for 3 h (3 h), 6 h, 12 h, 24 h, and 48 h; one
retina received DAPT (10 μM), while the sister retina served
as the DMSO vehicle control (Fig. 1A). Gross morphological
observations indicated that at 24 h, the retina treated with
DAPT was slightly smaller in size compared to its sister
control, and appeared more compacted and ruffled. We
quantified the levels of Notch-regulated genes by quantitative
RT-PCR (QPCR). Data is presented as the average fold
change between the DAPT-treated retina and control retina,
normalized to GAPDH levels (Figs. 1B–F). The inactivation
of Notch signaling caused a dramatic and rapid down-
regulation of Hes5 expression (Fig. 1B). This decline in Hes5
expression occurred as early as 3 h, and was maintained
throughout the culture period. There was also a 2-to 3-fold
decrease in Hes1 expression in DAPT-treated retinas from
12 h to 48 h (Fig. 1C). DAPT had relatively little effect on
Notch1 expression itself, although a decrease was apparent by
48 h (Fig. 1D). Expression levels of Myt1, a Notch antagonist(Mueller et al., 1995; Bellefroid et al., 1996; Matsushita et al.,
2002; Price et al., 2002), showed a transient ∼4-fold
upregulation from 12 to 24 h (Fig. 1E). Comparing the
relative changes in expression levels within this set of genes
reveals an intriguing pattern (Fig. 1F). Inactivation of Notch
signaling leads to a rapid reduction in the positive effectors of
this pathway (Hes5 and Hes1), and a later transient increase
in an antagonist of this pathway (Myt1), all of which would
act to promote neural differentiation.
Loss of Notch signaling reduces proliferation and progenitor
gene expression
To further characterize the effects of the loss of Notch
activity, we analyzed DAPT-treated E4.5 chick retinal explants
for changes in proliferation and progenitor gene expression.
Control and DAPT-treated retinas were labeled as wholemounts
for the mitotic marker phospho-Histone 3 (PH3) and analyzed
by laser scanning confocal microscopy (LSCM). Retinas treated
with DAPT for 48 h showed a large reduction in PH3+
progenitor cells compared to sister control retinas treated with
vehicle alone (Figs. 2A, B). Quantification of this effect
revealed ∼3-fold inhibition of proliferation due to loss of Notch
activity (Fig. 2C). To ensure that DAPT was not cytotoxic to
progenitor cells, we analyzed cell death after 6 h of culture and
found no significant difference in the number of propidium
iodide (PI) labeled cells between DAPT and DMSO treated
explants (Sup Figs. 1A–C).
We also analyzed levels of progenitor gene expression by
QPCR as described above. Chx10, Pax6, Pea3, c-Myb, and
Prox1 are all genes expressed in retinal progenitor cells
(Green et al., 2003; Marquardt et al., 2001; Dyer et al., 2003;
McCabe et al., 2006; Nelson and Reh, unpublished observa-
tions). Analysis of Chx10, Pax6, and Pea3 expression levels
over time indicates that between 12 h and 24 h progenitor cell
gene expression begins to decline; by 48 h expression levels
of all five progenitor genes had significantly decreased (Figs.
2D–G). Thus inhibition of Notch signaling leads to a
decrease in progenitor cell gene expression and reduction in
proliferation.
Loss of Notch signaling synchronizes neuronal differentiation
The loss of Notch activity causes a reduction of progenitor
cells, and therefore should lead to an increase in neural
differentiation. In the vertebrate retina, the first cell type to
differentiate is the ganglion cell (see Hartenstein and Reh, 2002
for review). We previously observed that loss of Notch activity
at embryonic day 3 (E3) caused an increase in ganglion cell
differentiation (Nelson et al., 2006). To assess the timing of
neural differentiation in E4.5 DAPT-treated explants, we
measured gene expression levels of Nell2 by QPCR. Nell2 is
a gene upregulated early during neural differentiation (Nelson et
al., 2002, 2004). Similar to Myt1, expression of Nell2 is
significantly upregulated between 6 h and 12 h, and it maintains
elevated expression levels throughout the duration of the culture
(Fig. 3E).
Fig. 1. Kinetics of Notch signaling inactivation. (A) Embryonic day E4.5 chick retinal explant pairs were collected and one explant was cultured in the presence of
DAPT (10 μM), while the sister explant was cultured in DMSO as a vehicle control. Images are of typical eye pairs and were taken at the indicated times. By 24 h of
culture, the explant treated with DAPT began to appear smaller and exhibit aberrant morphology, both of which became more apparent by 48 h. (B–E) QPCRwas used
to analyze changes in Hes5 (B), Hes1 (C), Notch1 (D), and Myt1 (E) gene expression levels over time due to inhibition of Notch signaling. For all QPCR experiments,
three pairs of explants were analyzed per timepoint, error bars represent standard deviation from the mean, single asterisk indicates a significant difference between
DAPT-treated explant compared to control at each timepoint as determined by one-way Student's t-test, double asterisks indicate significant changes between
timepoints as determined by ANOVA, and differences were considered significant at P<0.05. (F) Relative comparison of changes in gene expression levels over time.
Note that Hes5 expression levels are dramatically reduced by 3 h, and that Myt1 expression levels are transiently increased between 6 and 12 h after Notch signaling
inactivation.
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signaling leads to differentiation of other neurons such as cone
photoreceptors, another cell type generated early in develop-ment. Therefore, we analyzed additional sets of DAPT-treated
retinal explants at E4.5 for changes in the cone-specific marker,
Visinin (Yamagata et al., 1990; Bruhn and Cepko, 1996;
Fig. 2. Loss of Notch signaling reduces proliferation and progenitor gene expression. (A, B) E4.5 chick retinal explants pairs cultured for 48 h in DAPTor DMSOwere
wholemount immunolabeled with anti-phospho Histone 3 (PH3) antibody to reveal mitotic progenitor cells at the apical surface of the retina: images were acquired
from flatmounted explants with LSCM. (C) Quantification of PH3+ progenitor cells indicated that DAPT treatment significantly reduced proliferation ∼3-fold
compared to control; error bars indicate standard error of the mean, n=3 pairs, P<0.0186. (D–F) QPCR was used to analyze changes in Chx10 (D), Pax6 (E), and
Pea3 (F) gene expression levels over time due to DAPT treatment as described before. (G) Relative comparison of changes in progenitor gene expression levels over
time, including Prox1 and cMyb levels at the 48 h timepoint. Note that decline in expression levels are apparent by 24 h of Notch signaling inactivation.
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signaling caused a dramatic increase in Visinin immunolabeling
(Figs. 3A, B). We used QPCR to quantify the changes in
expression of both Visinin and retinoid X receptor-γ (RXR-γ),
an additional early marker for cones in chick (Hoover et al.,
1998). After 12 h of DAPT treatment, RXR-γ showed a small,
but significant increase in expression, and by 24 h both Visinin
and RXR-γ are upregulated by∼20- and ∼15-fold respectively
(Figs. 3C, D, compared in F).
Constitutively active NICD prevents DAPT-induced neuronal
differentiation
Although APP and Notch are the major substrates of the
presenilin/γ-secretase complex, other type I transmembrane
proteins have also been shown to be substrates for RIPping
(Medina and Dotti, 2003). To determine if the effects of DAPTare specific to presenilin/γ-secretase-mediated cleavage of
Notch in embryonic retinal progenitor cells, we tested whether
constitutively expressed NICD could prevent the ability of
DAPT to induce their differentiation. E5.5 chick retinas were
dissociated and transfected with a constitutively active NICD-
IRES-GFP plasmid (Daudet and Lewis, 2005) or GFP control
plasmid and cultured overnight. DAPT and DMSO were added
to each condition and cultured an additional 48 h. In GFP-
transfected cultures with the DMSO vehicle added, we
observed a mix of progenitor cells and differentiating neurons
typical of dissociated embryonic chick retinas (Fig. 4A).
DAPT treatment of GFP-transfected cultures resulted in loss of
cells with progenitor morphology and an increase in cells with
neuronal appearance (Fig. 4B). NICD transfection resulted in
clusters of cells with undifferentiated morphologies typical of
progenitors (Fig. 4C), or often isolated cells with differentiated
Muller glia-like morphology (Fig. 4D) in cultures treated with
Fig. 3. Loss of Notch signaling synchronizes neuronal differentiation. (A, B) E4.5 chick retinal explants pairs cultured for 48 h in DAPT or DMSO were wholemount
immunolabeled with anti-Visinin antibody to reveal differentiating cone photoreceptors in the apical retina: images were acquired from flatmounted explants with
LSCM. (C–E) QPCR was used to quantify changes in gene expression levels of Visinin (C) and RXR-γ (D), both of which are specifically expressed in differentiating
cones in chick, and Nell2 (E), which is generally expressed during neuronal differentiation, including ganglion cells and photoreceptors (Nelson et al., 2002; Nelson
and Reh, unpublished observations). (F) Relative comparison of changes in neuronal gene expression over time as described before. Note that the general neuronal
differentiation gene is upregulated by 12 h after Notch signaling inactivation, while cone specific genes are upregulated after 24 h.
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induce neuronal differentiation in NICD-transfected cells (Figs.
4E, F) as it did with GFP-transfected cells. Thus, NICD
prevented DAPT-induced neuronal differentiation, supporting
the notion that Notch is the major substrate of the presenilin/γ-
secretase complex responsible for the effects we observe on
retinal differentiation.
Notch activity regulates early and late retinal progenitors
To better determine whether DAPT-mediated inactivation of
Notch activity generated age-appropriate cell types, we analyzed
its effects at early and late stages of mouse retinogenesis, sincethis process occurs over a much shorter timescale in chick. Two
conditional genetic approaches based on the floxed Notch1
mouse (Radtke et al., 1999) were recently used to reduce Notch1
expression during mouse retinal development (Jadhav et al.,
2006; Yaron et al., 2006). Both studies report that genetic
removal of Notch1 in the early retina results in smaller eyes due
to premature progenitor cell differentiation into primarily cone
photoreceptors (Jadhav et al., 2006; Yaron et al., 2006). Jadhav
et al. (2006) also reported that removal of Notch1 later in
development caused an increase in rod photoreceptors and a
decrease in Muller glia. Thus we sought to determine to what
extent pharmacological inactivation of Notch activity can
recapitulate the phenotype observed by the genetic deletions.
Fig. 4. Constitutively active NICD prevents DAPT-induced neuronal differentiation. (A, B) DAPT induced differentiation of neuronal progenitors in the GFP-
transfected cells compared to control DMSO cultures: note the appearance of a large cluster of GFP+ progenitor cells found in a rosette (A, asterisk), surrounded by a
few GFP+ differentiated neurons (A, arrows), while many GFP+ differentiated neurons were present in DAPT-treated cultures (B, arrows). (C–F) Transfection of
NICD resulted in the appearance of large clusters of undifferentiated progenitor-like cells (C), or often isolated cells with morphologies consistent with differentiating
Muller glia (D) in DMSO-treated control cultures. In contrast to the many well-differentiated neurons in DAPT-treated GFP control cultures (B), DAPT-treated NICD
cultures still contained large clusters of NICD+ undifferentiated progenitor-like cells (E, F).
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48 h (the sister retina served as the DMSO vehicle control).
Gross morphological observations of the retina pairs indicated
that DAPT treatment caused a reduction in size as compared to
its sister control retina (Fig. 5A). Proliferation of progenitor cells
was inhibited by DAPT; both PH3 immunolabeling and BrdU
incorporation were reduced in DAPT-treated retinas (Figs. 5A′–
C). A similar analysis of explants from postnatal day 1 (P1)
retinas also demonstrated that explants treated with DAPTwere
smaller and had substantially reduced BrdU- and PH3-labeled
progenitor cells (Figs. 5D, E). QPCR analysis indicated that
DAPT treatment resulted in a significant reduction of Hes5 gene
expression levels by as early as 3 h, and that by 24 h both Hes5
and Hes1 transcripts declined (Fig. 5F). Additionally, fewerprogenitor cells in the neuroblast layer were labeled with Pax6
and Prox1 in DAPT-treated retinas (Figs. 5G, H).
Inhibition of Notch signaling with DAPT in mouse retinas
caused an increase in neuronal differentiation. There was an
increase in both ganglion cell- and cone-specific markers (Tuj1
and Isl1 Figs. 6A–F, Trβ2 Figs. 6G, H, respectively) in E12.5
DAPT-treated retinas, compared with control retinas. The
effects of DAPT treatment on neuronal differentiation in the
E12.5 retina were confined to those cell types generated early in
development: we found no labeling in either control or DAPT-
treated explants for later developing rod photoreceptor-specific
markers (Figs. 6I, J respectively). We compared the response of
E12.5 retina with that of P1 retina. Analysis of P1 explants
treated with DAPT indicated that there was no change in
Fig. 5. Notch signaling regulates proliferation of early and late retinal progenitor cells. (A–C) E12.5 pairs of mouse retinas were cultured with DAPT or DMSO for
48 h. The DAPT-treated retina was noticeably smaller than its sister control (A), and had less PH3+ progenitor cells (A′). Explants were pulsed with BrdU for 1 h prior
to fixation, sectioned and analyzed for BrdU incorporation and PH3 immunolabeling. Note that DAPT treatment drastically reduced the number of BrdU+ and PH3+
progenitors. (D, E) Similar analysis of pairs of P1 mouse retinal explants reveals DAPT treatment resulted in reduced retinal size, and number of BrdU+ and PH3+
progenitor cells; single asterisk marks central retina, double asterisk marks peripheral retina. (F) QPCR analysis of DAPT-treated explants resulted in a significant
decrease in Hes5 gene expression levels by 3 h, and both Hes5 and Hes1 levels by 24 h. (G, H) DAPT treatment at P1 also produced a clear decrease in Pax6/Prox1+/+
retinal progenitor cells (H, boxed area) compared to control (G, boxed area).
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contrast, later neuronal types, such as rod photoreceptors,
showed a clear increase in Recoverin and Rhodopsin immuno-
labeling (Figs. 6M–P).
Others have shown that effectors of the Notch signaling
pathway, such as Hes1, Hes5, and Hey2, are important forgenerating Muller glia cells (Tomita et al., 1996; Furukawa et al.,
2000;Hojo et al., 2000; Satow et al., 2001; Takatsuka et al., 2004),
and that conditional deletion of Notch1 in late retinal clones
resulted in a reduction of Muller glia (Jadhav et al., 2006). We
found that two Muller glial markers, CRALBP and CyclinD3,
were reduced in the DAPT-treated retinas (Figs. 6Q, R). Thus,
Fig. 6. Notch signaling inactivation promotes stage appropriate neuronal differentiation. (A–F) DAPT treatment of E12.5 mouse retina increased ganglion cell
differentiation, visualized by Tuj1 and Islet1 (Isl1) immunolabeling of sections (A, B and D, E) and wholemounts (C) and (F) respectively: asterisk in panels C and F
marks DAPT-treated explant. (G–J) DAPT treatment at E12.5 also increased cone photoreceptor differentiation visualized by Trβ2 immunolabeling (G, H), but not
later-born rod photoreceptors visualized by lack of Rhodopsin immunoreactivity in both control and DAPT-treated explants (I, J respectively). (K–R) DAPT treatment
at P1 had no effect on earlier-born Tuj1+ neurons (K, L), but produced a clear increase in both Recoverin and Rhodopsin immunolabeling of rod photoreceptors in the
apical region of the outer nuclear layer (M–P); also note the numerous newly generated rods in the more basal region of the outer nuclear layer (arrowheads, N, P).
DAPT treatment also produced a clear decrease in the differentiation of Muller glia cells, which have just begun to differentiate as visualized by CRALBP and Cyclin
D3 immunolabeling (Q, R).
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488 B.R. Nelson et al. / Developmental Biology 304 (2007) 479–498DAPT treatment at both early and late stages of mouse retinal
development reduced retinal size, the number of progenitor cells,
and Hes5 and Hes1 expression levels, in a manner similar to that
in the chick. DAPT treatment also initiated differentiation of
neuronal cell types specific to the stage at which they are
normally generated, and inhibited development of Muller glia.
Transient inactivation of Notch signaling initiates permanent
neural differentiation
It has been reported that a transient activation (24 h) of
Notch signaling causes a permanent switch in cultured neural
crest stem cells to undergo gliogenesis rather than neurogen-
esis (Morrison et al., 2000). To determine whether a transient
inactivation of Notch signaling can commit progenitor cells to
neural differentiation, we exposed developing retinas to
progressively longer periods of DAPT treatment. E4.5 chickFig. 7. Transient inactivation of Notch signaling synchronizes neural differentiation.
12 h, 24 h, washed extensively and cultured in DAPT-free media for a total of 48 h. E
size than their controls, which became more apparent with increased exposure to DAP
to PH3 and Visinin, and analyzed by LSCM as before. Exposure to DAPT for periods
controls, with a concomitant increase in Visinin immunoreactivity over time. No cha
DAPT exposure less than 6 h (Sup Figs. 2, 3).retinas were bisected and one half of the explant treated with
DAPT for 1 h, 3 h, 6 h, 12 h, 24 h, and 48 h, while the other
half of the explant served as a time-matched DMSO control.
After the period of DAPT exposure, the explants were washed
three times and cultured in DAPT-free media for a total of
48 h. They were then fixed and immunolabeled with antibodies
to PH3 and Visinin, and analyzed by LSCM as described
above.
While DAPT treatment for 1 h or 3 h did not alter retinal
development, periods of DAPT treatment for 6 h or longer
produced a clear effect on retinal development (Sup Fig. 2).
Inactivating Notch signaling for 6 h caused a noticeable
reduction in size, and this became more apparent with longer
exposures to DAPT (Fig. 7A). Permanent changes in progenitor
cell proliferation occurred from periods of 6 h or more of DAPT
treatment, and large regions devoid of PH3+ progenitors cells
were observed (Figs. 7B–D; Sup Fig. 2). There was a concurrent(A) Bisected E4.5 chick retinal explants were exposed to DAPT for 1 h, 3 h, 6 h,
xplants exposed to periods of DAPT treatment for 6 h were noticeably smaller in
T (asterisks). (B–D) Explants were wholemount immunolabeled with antibodies
of 6 h or longer produced a clear reduction in PH3+ progenitor cells compared to
nge in the pattern of PH3 or Visinin immunolabeling was observed in periods of
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DAPT for longer than 6 h (Figs. 7C, D, and data not shown).
We also found a consistent spatial sensitivity to the transient
inactivation of Notch signaling. Progenitor cells located in the
central region of the retina were more sensitive to a transient
decrease in Notch activity, while longer exposures to DAPT
were required to commit more peripheral progenitor cells to
differentiate. After 6 h of DAPT treatment, there was a
boundary between the differentiating central retina and the
seemingly normal peripheral region, which became more
apparent after 12 h of DAPT treatment (Sup Figs. 2, 3).
However, with 24 h of DAPT treatment, even peripheral regions
differentiated (data not shown).Fig. 8. Synchronized Notch signaling inactivation reveals an inherent proneural bH
changes in E4.5 chick retinal explant pairs treated with DAPTcompared to control ov
all exhibit statistically significant dynamic temporal changes over time due to Notch
three distinct transient and sequential responses: (1) Cash1 and Ngn2 were transiently
downregulated to below normal levels by 48 h; (2) NeuroM transiently increased late
Cath5 increased even later sometime after 6 h, with both peaking at 12 h: Cath5 decre
respectively).Synchronized Notch signaling inactivation initiates a proneural
bHLH cascade leading to differentiation
Although Hes5 gene expression was decreased by 3 h of
Notch signaling inactivation, the above results demonstrate that
a minimum of 6 h was required for progenitor cells to
permanently commit to differentiation. Proneural bHLH genes
are known to be direct targets of the Notch effectors, and are
important for proper neuronal differentiation (reviewed by
Fisher and Caudy, 1998; Bertrand et al., 2002; Quan and
Hassan, 2005). We hypothesized that a critical threshold of de-
repression of proneural bHLH genes must be achieved to
permanently commit progenitor cells to differentiation.LH cascade during progenitor cell differentiation. QPCR was used to analyze
er time as before. Cash1 (A), Ngn2 (B), NeuroM (C), NeuroD (D), and Cath5 (E)
signaling inactivation. (F) Comparing the relative patterns of changes reveal that
upregulated at 3 h, with Cash1 peaking at 6 h and Ngn2 peaking at 12 h, and both
r at 6 h, peaked at 12 h, and decreased to normal levels by 48 h; (3) NeuroD and
ased back to normal levels while NeuroD remained elevated by 48 h (Figs. 7D, E
490 B.R. Nelson et al. / Developmental Biology 304 (2007) 479–498We compared the temporal changes in expression of Cash1,
Ngn2, NeuroM, NeuroD, and Cath5 in DAPT-treated E4.5
chick retinal explants to those of controls by QPCR. Comparing
the relative changes of these genes revealed a dynamic set of
expression profiles that fell into three sequentially and
transiently upregulated groups. (1) Cash1 and Ngn2 were
upregulated by 3 h, and reached their peak expression levels at
6 h and 12 h respectively: both were downregulated to below
untreated levels by 48 h (Figs. 8A, B respectively). (2) NeuroM
expression was increased at 6 h, reached its peak expression by
12 h, and decreased to untreated levels by 48 h (Fig. 8C). (3)
NeuroD and Cath5 did not show increases until 12 h; Cath5
levels declined to those of untreated retinas by 48 h, while
NeuroD remained elevated (Figs. 8D, E respectively). These
results support the possibility that a critical threshold in either
Cash1 or Ngn2 might be reached within 6 h of inhibition of the
Notch pathway, thereby committing the progenitor cells to
terminal differentiation (Fig. 8F). Moreover, these results are
also consistent with the possibility that the various bHLH genes
in the retina are activated in a cascade, with the group 1 genes,Fig. 9. Summary of changes in cellular and molecular kinetics due to loss of Notch si
able to recover and remain progenitors (A, white to gray), even though Notch effect
treatment for 6 h or longer causes a permanent commitment to differentiate (large ar
genes by 12 h, with a concomitant decrease in expression of progenitor genes and an
signaling inactivation, decreased proliferation and widespread neuronal differentiatio
then early cell types such as cones and ganglion cells are generated (as depicted). If
types are observed, such as rods, along with concomitant decreased Muller glia differ
by synchronized Notch signaling inactivation underscores the temporal requirementlike Cash1 and Ngn2 activating “downstream” bHLH genes,
like NeuroM and Cath5.
Differential Notch activity within individual retinal progenitors
Transient manipulations of Notch activity, either inactivating
(this report) or activating (Morrison et al., 2000), suggest that
brief alterations in the levels of Notch activity within individual
progenitor cells can determine whether or not a progenitor cell
differentiates. Our results show that only a relatively short
period of Notch inactivation (6 h) is sufficient to commit a
progenitor to differentiate, and suggest a model in which
fluctuations in the level of Notch signaling in progenitors
underlies the normal mechanism for differentiation. Tokunaga
and colleagues demonstrated that different levels of activated
Notch are observed in progenitor cells in the nervous system
during development (Tokunaga et al., 2004), although retinal
expression was not reported (Fig. 9). To determine if retinal
progenitor cells exhibit different levels of activated Notch
signaling, we used an antibody specific to the γ-secretase-gnaling. Cycling progenitor cells that receive a pulse of DAPT for 3 h or less are
or genes have been downregulated (B). However exposure to periods of DAPT
rows). Committed progenitor cells increase expression of general differentiation
increase in expression of cell-type specific genes by 24 h. By 48 h after Notch
n are readily apparent. If Notch signaling is inactivated in early in development,
Notch is inactivated during late retinal development, then increases in later cell
entiation. The inherent cascade of proneural bHLH transcription factors initiated
for progenitor cells to permanently commit to neuronal differentiation.
491B.R. Nelson et al. / Developmental Biology 304 (2007) 479–498mediated cleavage product NICD (ActN1, as in Tokunaga et al.,
2004). At E14.5, ActN1 is confined to the neuroblast layer of
the developing retina, and restricted from the ganglion cell layerFig. 10. Notch signaling activity fluctuates in mitotic retinal progenitor cells. E14.
activated form of NICD (ActNotch1, purple cells) to determine the pattern of Notch
neuroblast layer of the retina (brackets), but not in the ganglion cell layer (gc) or in
Also, note that subpopulations of cells are more heavily labeled than others (arrow
immunolabeling (arrows) is not observed in Tuj1+ differentiating neurons (red cells
sections from an E14.5 mouse embryo that received a 1 h pulse of BrdU in utero prior
for PH3 and BrdU incorporation, and counterstaining with Dapi. Panels are arranged t
BrdU (green), (I) actNotch1, PH3, and BrdU, (J) PH3, BrdU, and Dapi. (F′–I′) Inset
Same insets are shown overlayed onto Dapi to facilitate comparison: actNotch1+/B
mitotic surface are marked with arrowheads. Higher levels of activated Notch are oand peripheral regions where the ciliary body and iris would be
located (Fig. 10A). Within the neuroblast layer, ActN1 is not
expressed in the differentiating neurons (TuJ1+), but only in5 mouse retinal sections were immunolabeled with an antibody specific to the
activity in situ (Tokunga et al., 2004). (A, B) Notch activity is observed in the
peripheral regions where the ciliary body and iris would be located (A, arrows).
heads; A, transverse section; B, oblique transverse section). (C–E) ActNotch1
, arrowheads). (F–J) To observe Notch activity within retinal progenitor cells,
to sacrifice were sequentially processed for actNotch1 staining, immunolabeling
o show (F) actNotch1 (purple), (G) actNotch1 and PH3 (red), (H) actNotch1 and
s from panels F–I are shown at higher magnification respectively. (F′′–H′′, J′′)
rdU+ progenitor cells are marked with asterisks; PH3+ progenitor cells at the
bserved in S-phase progenitor cells compared to M-phase progenitor cells.
Fig. 11. Identification of new components involved in the initial program of
progenitor cell differentiation. E14.5 mouse retinal explants were treated with
DAPT or DMSO for 8 h, and global changes in gene expression due to DAPT
treatment were compared by microarray analysis (Affymetrix Mouse Genome
430 2.0; Supp Fig. 4). QPCR was used to confirm changes in expression levels
of selected genes identified from the microarray analysis as before: note that
similar genetic changes are observed at this early timepoint in mouse and chick
(Hes and proneural bHLH genes). Additionally, microarray/QPCR analysis
identifies changes in other signaling systems such as FGF, Wnt, and IGF
pathways, changes in other gene family members such as Delta 1/4 and Hes6,
and finally previously uncharacterized genes during retinal development such as
Insulinoma-associated 1 (Insm1).
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S-phase progenitor cells and lower levels of ActN1 are observed
in M-phase progenitor cells (Figs. 10F–J), similar to progenitor
cells elsewhere in the nervous system (Tokunaga et al., 2004).
These data show that Notch signaling activity changes during
the cell cycle, reaching a low point during M-phase.
Synchronized Notch signaling inactivation reveals new
components in the initial program of progenitor cell
differentiation
To determine the scope of molecular changes during the
initial phase of Notch signaling inactivation, we compared
global gene expression of E14.5 mouse retinal explants treated
with DAPT for 8 h, to that of controls, using microarray analysis
(Affymetrix Mouse Genome 430 2.0 Array, Sup Fig. 4). We
used QPCR to validate changes in expression levels of selected
genes from the array (Fig. 11). The microarray/QPCR analysis
confirmed that Hes1 and Hes5 are downregulated with DAPT
treatment (Fig. 11; Sup Fig. 4). By contrast, the proneural
bHLHs Mash1, Ngn2, NeuroD1, and Math5 were upregulated
in DAPT-treated retinas (Fig. 11; Sup Fig. 4). Additionally,
microarray/QPCR analysis identifies changes in expression
levels of other members of the Hes and proneural bHLH
families: Idb3, Idb4, and Dtx4 are downregulated while Hes6 is
upregulated; Bhlhb5 is upregulated while Bhlhb2 is down-
regulated (Fig. 11; Sup Fig. 4). The upregulation of Bhlhb5 is
intriguing, as it has recently been shown to regulate amacrine
and cone bipolar formation (Feng et al., 2006). Thus at E14.5,
an increase in Bhlhb5 expression would likely correlate with
increased amacrine differentiation, further demonstrating that
Notch signaling also regulates the genesis of this cell type in the
early retina. Expression of the Notch ligands Dll1 and Dll4 are
upregulated (Fig. 11). Thus, DAPT-treatment causes a coordi-
nated response amongst Notch signaling pathway components,
including Notch effector genes, proneural bHLH transcription
factors, and Notch ligands (Fig. 11, Sup Fig. 4). Furthermore,
QPCR confirms the majority of changes observed by micro-
array analysis, indicating a high degree of correlation between
the two methods.
Changes in genes associated with other signaling pathways
were also observed: Fgf3, 13, and 15, the Wnt inhibitors
Sfrp2 and Dkk3, and insulin growth factor binding proteins
Igfbp 1,4, all showed decreased expression by 8 h of DAPT
treatment (Fig. 11). Chx10 and Rax, homeodomain transcrip-
tion factors associated with retinal progenitor cells, already
indicate reduced gene expression levels by 8 h of DAPT-
treatment (Fig. 11). Additionally, changes were observed in
transcription factors and/or DNA-binding proteins previously
not characterized as regulated by Notch input during retinal
development. Notably, Nr2e1 (Tlx), an orphan nuclear
receptor known to be essential for retinal progenitor cell
proliferation (Miyawaki et al., 2004; Zhang et al., 2006), is
substantially downregulated by 8 h of Notch signaling
inactivation. Conversely, Sox4 and Sox11 have begun to be
upregulated by this time (Fig. 11), consistent with possibility
that some Sox family members function to promoteprogenitor cell differentiation, such as that observed in the
spinal cord with Sox1–3 and Sox21 activities (Bylund et al.,
2003; Sandberg et al., 2005). Repressor protein 58 (RP58)
and insulinoma-associated 1 (Insm1) are zinc-finger proteins
that are upregulated due to Notch signaling inhibition (Fig.
11). RP58 is a DNA-binding protein that mediates sequence-
specific transcriptional repression from E-box motifs, is
associated with heterochromatin, and recruits a corepressor
complex with Dnmt3a methylase and HDAC1 histone
deacetylase (Aoki et al., 1998; Meng et al., 2000; Fuks et
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endocrine cell differentiation in the pancreas (Gierl et al.,
2006), and is regulated by NeuroD1 and Ngn3 (Breslin et al.,
2003; Mellitzer et al., 2006); its function during retinal
development is not known. Finally, many components of the
cell cycle machinery were observed to change after 8 h of
Notch signaling inactivation (data not shown), two of which
were Btg2 and CyclinD1. Btg2 expression increased afterFig. 12. Insulinoma-associated 1 (Insm1) is expressed early during retinal developmen
expression during early retinal development (Lan et al. reference). Insm1:LacZ activ
Insm1:LacZ expression in a discrete subpopulation of cells distributed through the ce
primarily confined to the ventricular surface (D, arrow). (E–G) PH3 immunolabeling
(red, arrowheads) are not Insm1:LacZ+ (blue, asterisks), although one Insm1:LacZ+
stage reveals that Insm1:lacZ+ cells (asterisks) in this outer layer are also not Tuj1+DAPT treatment, and its activity is linked to increased
lengthening of the cell cycle and progression toward neuronal
differentiation (Iacopetti et al., 1999; Calegari et al., 2005). A
slightly increased level of CyclinD1 was also observed,
although this would be the opposite of what would be
predicted upon synchronized differentiation. However, as
many other cell cycle components also showed increased or
decreased expression levels as well, it remains to bet. E12.5 and E14.5 Insm1-LacZ transgenic mice were used to characterize Insm1
ity is detected in the developing eye early at E12.5 (A, arrow). Sections reveal
ntral retina (B, arrow). By E14.5 Insm1:LacZ expression in the eye (C, arrow) is
reveals that at this stage (E14.5) the majority of PH3+ mitotic progenitor cells
/PH3+ cell was observed (arrow). (H–J) However, Tuj1 immunolabeling at this
(red, arrowheads).
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cycle machinery intersect.
To validate this approach for the identification of novel
components of the neuronal differentiation pathway, we
analyzed the expression of Insm1, a zinc-finger transcription
factor regulated by proneural bHLH transcription factors.
Insm1 has been shown to mediate differentiation of newly
born endocrine cells in the pancreas (Breslin et al., 2003;
Gierl et al., 2006; Mellitzer et al., 2006) and a transgenic
Insm1:LacZ reporter mouse has been generated (Breslin et al.,
2003). We used this mouse line to determine what cell type(s)
express Insm1 during retinal development. Insm1:LacZ
reporter is expressed in a discrete population of cells in the
central retina at E12.5 (Figs. 12A, B). By E14.5, Insm1:LacZ
is primarily restricted to cells located at the ventricular
surface, although an occasional cell is observed in the
ganglion cell layer (Figs. 12C, D). PH3 immunolabeling
reveals that the majority of Insm1:LacZ+ cells at the
ventricular surface are not dividing progenitor cells (Figs.
12E–G) or Tuj1+ differentiating ganglion cells migrating to
the ganglion cell layer (Figs. 12H–J), although one Insm1:
LacZ+/PH3+ cell was observed. Therefore, Insm1 is likely
expressed very early during differentiation, most likely in
newly born photoreceptors at this age, which have previously
been shown in this layer (Hinds and Hinds, 1979; Furukawa
et al., 1997; Roberts et al., 2005).
Discussion
In this report, we show that pharmacological inhibition of
Notch signaling can phenocopy the experimental results
obtained with other methods, but allows for better temporal
control over the differentiation process. Treatment of develop-
ing retina with DAPT causes the following: (1) a rapid decline
in downstream components of the Notch signaling pathway that
initiates a molecular cascade leading to synchronized differ-
entiation of progenitors; (2) a stage dependent differentiation of
the various retinal cell types; (3) a permanent commitment to
differentiation after transient exposure; and (4) an inherent
cascade of proneural bHLH gene expression underlying the
entire process. Thus, DAPT provides a powerful tool for the
synchronization of the cell differentiation processes regulated
by Notch activity.
DAPT recapitulates genetic manipulation of Notch signaling
pathway components
Deletion of Notch1 causes early embryonic lethality prior to
retinal development (Conlon et al., 1995; De la Pompa et al.,
1997), but recently two studies have reported the effects of a
Notch1 conditional knockout (CKO). These mice have smaller
eyes, reduced progenitor cell proliferation, and increased
differentiation of cone photoreceptors early (Jadhav et al.,
2006; Yaron et al., 2006) and rod photoreceptors later (Jadhav et
al., 2006). We report that DAPT treatment has similar effects:
the DAPT-treated retinas are smaller, have decreased prolifera-
tion, and increased neuronal differentiation. DAPT also causespremature differentiation of cone photoreceptors in embryonic
retina, and differentiation of rod photoreceptors in postnatal
retina. In addition, both Notch1 CKO (Jadhav et al., 2006) and
DAPT treatment result in an inhibition of Muller glia
differentiation. Thus, the effects of DAPT treatment are
consistent with, and confirm, the results of the Hes1, Hes5,
and the Notch1 CKO genetic studies.
However, there is one main difference between the Notch1
CKO studies and our results with DAPT: DAPT treatment
causes an increase in ganglion cell differentiation that was
not observed in either Notch1 CKO study. This discrepancy
may be due in part to the timing and variability of expression
of the Chx10-Cre driver from one study (Rowan and Cepko,
2004; Jadhav et al., 2006), or the α-Pax6-Cre driver from the
other study (Yaron et al., 2006) used to conditionally delete
Notch1 in the retina. The difference may also be due to
redundancy between Notch family members: both Notch1
and Notch3 are expressed in the early neural retina (Lindsell
et al., 1996). DAPT treatment caused a large reduction in
Hes5 and Hes1 expression, as did the α-Pax6-Cre Notch1
CKO (Yaron et al., 2006), but the Chx10-Cre Notch1 CKO
did not (Jadhav et al., 2006). An analogous study in the
cortex demonstrating functional redundancy between Notch1
and Notch3 was accompanied by loss of Hes5 and Hes1 in
the retina (FoxG1-Cre, Mason et al., 2005). Our results in the
developing chick and mouse retina are also somewhat
different from those in zebrafish (Bernardos et al., 2005). A
different γ-secretase inhibitor (Compound E) caused a
disruption in lamination, a change in cone spectral subtype,
and an inhibition of Muller glia development, but neither
mindbomb mutation nor Compound E caused a premature
depletion of the progenitor pool (Bernardos et al., 2005). The
difference between fish and other vertebrates may be due to a
difference in the rate of development. Rapidly developing
systems may not rely on Notch signaling for maintaining
their progenitor pool, whereas systems requiring prolonged
times for development are more sensitive to this aspect of
Notch signaling activity. Nevertheless, DAPT treatment
phenocopies various aspects of other Notch pathway muta-
tions in zebrafish and Drosophila (Geling et al., 2002;
Micchelli et al., 2003).
It is possible that some of the effects we observe with
DAPT are due to inhibition of other presenilin/γ-secretase
substrates. However, we consider this unlikely for several
reasons. First, overexpression of the NICD in retinal
progenitors prevented their DAPT-mediated differentiation
(Fig. 4). Second, many of the known components of the
Notch signaling pathway changed in predictable ways due to
DAPT treatment (Sup Fig. 4, Fig. 11). Third, we did not
observe a change in most of the target genes from presenilin/
γ-secretase substrates other than the Notch pathway (e.g. APP
and the amyloid precursor-like protein APLP1; Hebert et al.,
2006). Although, we observed a small decrease in APLP2 and
an increase in GSK3β expression (one of the putative targets
of APLP2; Xu et al., 2006), these changes were in the
opposite direction of what would be predicted by inhibition of
APLP2 processing.
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progenitor cells to differentiate
While previous studies of neural crest stem cells have shown
that exposure to an activating Notch signal for 24 h irreversibly
committed these cells to glia (Morrison et al., 2000), the period
of Notch inactivation needed for irreversible commitment to
differentiation was not known. Our experiments show that less
than 6 h of DAPT exposure allows the progenitors to recover
and remain in the cell cycle, but periods of DAPT treatment
longer than this lead to differentiation. It is not clear why 6 h is
the critical time for Notch inactivation to commit progenitors to
differentiate, since Notch activity is down-regulated after only
3 h (summarized in Fig. 9).
One possibility may relate to the observations that Notch is
normally active only during the S-phase of the cell cycle, and
not during M-phase (Fig. 10; Tokunaga et al., 2004). If
substantially shorter periods of Notch inactivation were
required to commit cells to differentiate, the cells would not
have sufficient time for the mitotic phase of the cycle. The
length of M-phase may thus serve as a limit to the length of time
during which Notch can be inactive, yet still preserve the cell in
an undifferentiated state. While this does not explain why Notch
activity oscillates with the cell cycle, it may explain why
preventing cells from exiting M-phase promotes their differ-
entiation (Murciano et al., 2002).
An alternative explanation for the minimum 6 h requirement
is that another factor reaches a critical threshold at this time.
Since the proneural bHLH genes are immediate targets of Hes1/
5, they seemed likely candidates for this role. Indeed, Cash1,
Ngn2, and NeuroM show significant increases in expression
after 6 h of DAPT treatment (summarized in Fig. 9). Low level
expression of proneural bHLH genes is necessary for expression
of Notch pathway components in neural progenitor cells; e.g.
Delta1 (Fode et al., 1998; Ohsawa et al., 2006) and Hes1/5
(Castro et al., 2005; Lamar and Kintner, 2005). However,
overexpression of Mash1 or Ngn2 promotes cell cycle
withdrawal, migration away from the ventricular zone, and
neuronal differentiation (Simmons et al., 2001; Novitch et al.,
2001; Bylund et al., 2003; Lee and Pfaff, 2003; Sandberg et al.,
2005; Helms et al., 2005; Fior and Henrique, 2005). Moreover,
Tokunaga et al. (2004) found that forebrain progenitor cells
expressing high levels of either Ngn2 or Mash1 had the lowest
levels of ActN1 (Tokunaga et al., 2004). Therefore, while neural
progenitor cells normally express proneural bHLH genes,
increased expression beyond a threshold level could commit
them to differentiate.
As noted above, the timing of changes in expression of the
bHLH transcription factors in both chick and mouse following
DAPT treatment is consistent with a cascade in their function.
Cash1 and Ngn2 were upregulated by 3 h, while NeuroM
expression was upregulated after 6 h and NeuroD and Cath5 did
not show increases until 12 h. It has been proposed that
proneural bHLH transcription factors operate as a cascade,
whereby upstream bHLHs in progenitor cells induce down-
stream bHLHs to promote neural differentiation. Intriguingly,
there is evidence that Mash1/Ngn2 induce such cascades in theolfactory epithelium, spinal cord, and somewhat in the retina
(Cau et al., 1997; Novitch et al., 2001; Lee and Pfaff, 2003;
Bylund et al., 2003; Skowronska-Krawczyk et al., 2004;
Sandberg et al., 2005; Fior and Henrique, 2005; Matter-
Sadzinski et al., 2005). It is striking that such a temporally
distinct and dynamic cascade of bHLH gene expression is
observed after synchronized Notch inactivation, which allowed
us to more comprehensively visualize this cascade in the retina
for the first time.
Synchronizing progenitor cell differentiation identifies new
components of the differentiation program
Microarray/QPCR analysis of DAPT treated retinas allowed
us to identify new components of the differentiation program of
neural progenitor cells. Characterization of Insm1, one of the
genes upregulated after 8 h of DAPT treatment, validates our
approach to discover new pathways operating during initial
stages of progenitor cell differentiation. Insm1 is particularly
interesting in regard to its function during endocrine cell
differentiation in the pancreas and gut. Deletion of Insm1
completely stalls the differentiation of endocrine precursor cells
(Gierl et al., 2006). Proneural bHLH genes Ngn3 and NeuroD1
regulate Insm1 expression in endocrine precursor cells (Breslin
et al., 2003; Mellitzer et al., 2006), and Insm1 seems to feedback
to repress NeuroD1 activity (Liu et al., 2006). Analysis of retinas
from Insm1:LacZ reporter mice reveals that Insm1 is likely
expressed in newly differentiating photoreceptors at this age
(Fig. 12). It will be interesting to determine whether Insm1 has a
similar role in promoting downstream events in differentiating
photoreceptors, and how proneural bHLH genes regulate Insm1
expression. Among the bHLH transcription factors that were
upregulated after DAPT treatment was Bhlhb5. Gan and
colleagues recently reported that Bhlhb5 is required for the
differentiation of amacrine cells and subtypes of cone bipolar
cells (Feng et al., 2006). Increased expression of Bhlhb5 in our
experiments at E14.5–E15.5 likely reflects increased amacrine
cell differentiation (Fig. 11). Thus, this approach also demon-
strates that synchronized Notch signaling inactivation reveals
molecular changes associated with the differentiation of age
appropriate cell types. Our approach also revealed a Notch
signaling input in Fgf, Wnt, and insulin signaling pathways (Fig.
11). The mechanism through which Notch signaling regulates
these diverse pathways remains to be elucidated. Further
analysis of additional time-points should provide more informa-
tion about the temporal dynamics of the molecular program of
progenitor cell differentiation.
It has been proposed that there is a “clock” in retinal
progenitor cells, likely reflecting changing competence as time
goes by. Simply triggering the inactivation of Notch at
progressively later stages of retinal development provides a
mechanism to generate a sequence of different types of cells
(Reh and Cagan, 1994; Cepko et al., 1996). Components of the
Notch pathway are known to function in a “clock-like” manner
(discussed by Bessho and Kageyama, 2003), although it
remains unclear how a Notch regulatory “clock” intersects
with the observed changes in competency of progenitor cells
496 B.R. Nelson et al. / Developmental Biology 304 (2007) 479–498over time. Notch activity may act simply to reset the clock
during each cell cycle, while integration of other intrinsic and
extrinsic signals may regulate the competence to differentiate
into a specific cell type at a given time (Li et al., 2004; Kim et
al., 2005). Alternatively, Notch activity itself may progressively
limit progenitor competence by a ratchet-like mechanism, such
that each cell cycle results in a smaller repertoire of fate decision
available to progenitors over time. Synchronization of progeni-
tor cell differentiation should allow a systematic analysis of this
process.
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